• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Regulation of anti-tumor immunity by targeting cyclooxygenase-2 expressing cells

Research Project

  • PDF
Project/Area Number 23701076
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Tumor immunology
Research InstitutionKyoto University (2012-2013)
Kitasato University (2011)

Principal Investigator

INOUE Joe  京都大学, 医学(系)研究科(研究院), 助教 (00433714)

Project Period (FY) 2011 – 2012
Keywordscox-2 / tumor / dendritic cell / liposome
Research Abstract

The immunosuppression in tumor tissue has been attributed to tumor cells expressing cyclooxygenase (COX) -2. From this study, COX-2 was also expressed in tumor infiltrated CD11c+ cells. It was shown that through the production of immunosuppressive cytokines by COX-2+CD11c+ cells, the cells are largely responsible for immunosuppression in tumor tissues. Moreover, liposome (COX-2 selective inhibitors encapsulated liposome) which newly prepared to target the COX-2+CD11c+ cells, it showed the possibility to improve the immunosuppression by COX-2+CD11c + cells in tumor tissues.

  • Research Products

    (3 results)

All 2013 Other

All Journal Article (2 results) (of which Peer Reviewed: 2 results) Remarks (1 results)

  • [Journal Article] Liposomal lipopolysaccharide initiates TRIF-dependent signaling pathway independent of CD142013

    • Author(s)
      Watanabe S, Kumazawa Y, Inoue J
    • Journal Title

      PLoS One.

      Volume: 8(4) Pages: e60078

    • Peer Reviewed
  • [Journal Article] Intracellular delivery of lipopolysaccharide induces effective Th1-immune responses independent of IL-122013

    • Author(s)
      Watanabe S#, Inoue J#*
    • Journal Title

      PLoS One.

      Volume: 8(7) Pages: e68671

    • Peer Reviewed
  • [Remarks]

    • URL

      http://www.med.kyoto-u.ac.jp/organization-staff/research/doctoral_course/r-010/

URL: 

Published: 2015-06-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi